We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.43B
AUM Growth
+$23.4M
Cap. Flow
-$14M
Cap. Flow %
-0.98%
Top 10 Hldgs %
37.26%
Holding
167
New
14
Increased
36
Reduced
54
Closed
10

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$15.5M
2
PFE icon
Pfizer
PFE
+$6.18M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.32M
4
HRB icon
H&R Block
HRB
+$2.32M
5
PEP icon
PepsiCo
PEP
+$1.41M

Top Sells

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$17.2M
2
FLEX icon
Flex
FLEX
+$7.35M
3
PPLI
People Inc
PPLI
+$7.22M
4
AMZN icon
Amazon
AMZN
+$4.45M
5
GLW icon
Corning
GLW
+$3.27M

Sector Composition

Rank Sector Weight
1 Technology 36.12%
2 Financials 18.14%
3 Communication Services 14.85%
4 Healthcare 11.53%
5 Consumer Discretionary 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTES icon
101
NetEase
NTES
$79.1B
$1.21M 0.08%
21,525
– –
NVS icon
102
Novartis
NVS
$300B
$1.21M 0.08%
16,628
– –
BDX icon
103
Becton Dickinson
BDX
$43.9B
$1.19M 0.08%
5,630
-1,059
-16% -$232K
AMBA icon
104
Ambarella
AMBA
$2.82B
$1.18M 0.08%
24,070
– –
CVS icon
105
CVS Health
CVS
$136B
$1.18M 0.08%
18,900
– –
V icon
106
Visa
V
$688B
$1.14M 0.08%
9,502
– –
PANW icon
107
Palo Alto Networks
PANW
$264B
$1.07M 0.07%
35,400
– –
VTRS icon
108
Viatris
VTRS
$20.4B
$1.05M 0.07%
25,400
– –
NVO
109
Novo Nordisk
NVO
$220B
$1.01M 0.07%
41,000
– –
ENDP
110
DELISTED
Endo International plc
ENDP
$1.01M 0.07%
169,570
+3,000
+2% +$21K
KEM
111
DELISTED
KEMET Corporation
KEM
$809K 0.06%
+44,595
New +$816K
NXGN
112
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$801K 0.06%
58,700
-2,443
-4% -$32.2K
SEDG icon
113
SolarEdge
SEDG
$2.58B
$758K 0.05%
14,415
-13,635
-49% -$598K
MGLN
114
DELISTED
Magellan Health Services, Inc.
MGLN
$737K 0.05%
6,885
– –
CSGS
115
DELISTED
CSG Systems International
CSGS
$736K 0.05%
16,255
– –
MA icon
116
Mastercard
MA
$487B
$725K 0.05%
4,139
– –
KLIC icon
117
Kulicke & Soffa
KLIC
$5.07B
$696K 0.05%
27,845
– –
PRFT
118
DELISTED
Perficient Inc
PRFT
$668K 0.05%
29,165
– –
IQ icon
119
iQIYI
IQ
$1.21B
$656K 0.05%
+42,160
New +$656K
CVSA
120
Covista Inc
CVSA
$4.02B
$612K 0.04%
12,875
– –
AAN.A
121
DELISTED
The Aaron's Company Inc Class A
AAN.A
$610K 0.04%
13,090
– –
MERC icon
122
Mercer International
MERC
$44.1M
$577K 0.04%
46,335
– –
AUB icon
123
Atlantic Union Bankshares
AUB
$6.03B
$557K 0.04%
15,185
– –
SAM icon
124
Boston Beer
SAM
$1.91B
$526K 0.04%
2,780
– –
UTHR icon
125
United Therapeutics
UTHR
$26.5B
$511K 0.04%
4,545
– –
3 4
5
6 7

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Oak Associates held 167 positions worth $1.43B, up 1.7% from $1.41B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Oak Associates's Q1 2018 filing shows 14 new, 36 increased, 54 reduced and 10 closed positions. Its largest new stake was KEMET Corporation: 44,595 shares worth $809K. The largest sale was Wells Fargo, an estimated $17.2M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Communication Services.

  • Oak Associates's largest Q1 2018 buy was KEMET Corporation: 44,595 shares worth $809K.
  • Oak Associates added most to Gilead Sciences in Q1 2018, an estimated $15.5M increase.
  • Oak Associates's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $17.2M.
  • Oak Associates fully exited Flex in Q1 2018, selling an estimated $7.35M.
  • Oak Associates's ten largest holdings make up 37% of its $1.43B portfolio in Q1 2018.
  • Oak Associates opened 14 new positions and closed 10 in Q1 2018.
  • Oak Associates's portfolio value rose 1.7% quarter-over-quarter to $1.43B.

Based on Oak Associates's 13F filing for Q1 2018, filed 14 May 2018.